Published in Lab Law Weekly, August 19th, 2005
Hemberger joins the board as Edward M. Scolnick, MD, who has served on the company's board since August 2001, resigns to focus on his responsibilities as director of the Psychiatric Disease Initiative at the Broad Institute of MIT. Scolnick will continue to advise Renovis on scientific matters as a member of the company's Medical and scientific advisory board (MSAB). Renovis' board of directors remains at nine members.
"We are grateful to Scolnick...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly